Australia markets open in 43 minutes

BioHarvest Sciences Inc. (8MV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1510+0.0010 (+0.67%)
At close: 03:44PM CET

BioHarvest Sciences Inc.

1140-625 Howe Street
Vancouver, BC V6C 2T6
604 622 1186

Sector(s)Consumer Defensive
IndustryPackaged Foods
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Zaki Rakib Ph.D.Co-Founder, Executive Chairman & President218.04kN/A1959
Mr. Ilan SobelChief Executive Officer481.05kN/AN/A
Dr. Yochi Hagay Ph.D.Co-Founder, CTO & Member of Scientific Advisory BoardN/AN/A1959
Mr. David K. RyanVP of Investor Relations, Secretary & Director42.92kN/A1967
Dr. Ilana Belzer Ph.D.Chief Operating OfficerN/AN/A1960
Dr. Brian S. CornblattChief Medical Officer & Member of Scientific Advisory BoardN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. It engages in research and development of science based therapeutic solutions for the nutraceutical industry; and plant cell-based active pharmaceutical ingredients that can assist in the treatment of specific medical indications The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.

Corporate governance

BioHarvest Sciences Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.